U.S. Markets close in 6 hrs 18 mins

Biohaven Pharmaceutical Holding Company Ltd. (BHVN)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
127.14-0.22 (-0.17%)
As of 9:38AM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.00
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3128.73
52 Week Low 357.66
50-Day Moving Average 3106.98
200-Day Moving Average 385.47

Share Statistics

Avg Vol (3 month) 3704.42k
Avg Vol (10 day) 3473.5k
Shares Outstanding 565.07M
Implied Shares Outstanding 6N/A
Float 55.02M
% Held by Insiders 112.38%
% Held by Institutions 1109.38%
Shares Short (Jun 14, 2021) 46.16M
Short Ratio (Jun 14, 2021) 48.96
Short % of Float (Jun 14, 2021) 410.68%
Short % of Shares Outstanding (Jun 14, 2021) 49.47%
Shares Short (prior month May 13, 2021) 45.4M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)-686.85%

Management Effectiveness

Return on Assets (ttm)-59.42%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)106.3M
Revenue Per Share (ttm)1.77
Quarterly Revenue Growth (yoy)3,707.40%
Gross Profit (ttm)45.93M
EBITDA -716.09M
Net Income Avi to Common (ttm)-858.83M
Diluted EPS (ttm)-14.28
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)566.26M
Total Cash Per Share (mrq)8.7
Total Debt (mrq)455.38M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.28
Book Value Per Share (mrq)-4.24

Cash Flow Statement

Operating Cash Flow (ttm)-757.83M
Levered Free Cash Flow (ttm)-500.64M